Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin [Oncotarget, 7, (2016) (27641-27654)]. DOI:10.18632/oncotarget.8505

Yu Chen S.H. Yang, Yu Tang Chin, Meng Ti Hsieh, Hsuan Yu Lai, Chien Chih Ke, Dana R. Crawford, Oscar K. Lee, Earl Fu, Shaker A. Mousa, Patricia Grasso, Leroy F. Liu, Heng Yu Chang, Heng Yuan Tang, Hung Yun Lin, Paul J. Davis

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)35480
Number of pages1
JournalOncotarget
Volume8
Issue number21
DOIs
Publication statusPublished - 2017

ASJC Scopus subject areas

  • Oncology

Cite this

Yang, Y. C. S. H., Chin, Y. T., Hsieh, M. T., Lai, H. Y., Ke, C. C., Crawford, D. R., Lee, O. K., Fu, E., Mousa, S. A., Grasso, P., Liu, L. F., Chang, H. Y., Tang, H. Y., Lin, H. Y., & Davis, P. J. (2017). Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin [Oncotarget, 7, (2016) (27641-27654)]. DOI:10.18632/oncotarget.8505. Oncotarget, 8(21), 35480. https://doi.org/10.18632/oncotarget.18067